August 28, 2008

The horse of US dressage rider Courtney King returned a positive test to a medication class A prohibited substance at the Olympic Games in Hong Kong.

Mythilus tested positive for the banned substance Felbinac, which is applied topically for the relief of local pain and inflammation and belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).


Courtney King and Mythilus © 2007 Terri Miller
King placed 13th individually in the dressage competition, and was a member of the US team which placed fourth. She was officially notified on the morning of 22 August of the positive test result and the decision for provisional suspension was upheld that evening at a preliminary hearing before one member of the FEI Tribunal.

Given that the dressage events of the 2008 Olympic Games ended on 19 August it was decided to wait until the confirmatory B analysis before any public announcement of the findings. The FEI has now received confirmation of the initial finding from the analysis of the B sample.

Four showjumpers have also had their B samples confirmed positive.

The process will now follow the Accelerated Medication Control Procedure during and after the 2008 Olympic Games which is part of the FEI Regulations for Equestrian events at the 2008 Games (Annex G).

Evidence and written submissions have been requested from King, and a three-member panel of the FEI Tribunal has been appointed.

An update will be provided by the FEI following the hearings and final decisions will be announced before the end of the first week in October, provided the hearings can be held as scheduled.

The competition results will be amended as indicated in the Tribunal's final decision.